Bolt Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary

Bolt Biotherapeutics

12/08/2021 22:35

* Bolt Biotherapeutics Inc  BOLT.OQ  reported a quarterly
adjusted loss of 64 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 43 cents per share.
* Reported revenue was zero​;  analysts expected $3.33 million. 
* Bolt Biotherapeutics Inc's reported EPS for the quarter was a
loss of 64 cents​.
* The mean earnings estimate of analysts had risen by
about 15.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Bolt Biotherapeutics Inc shares had fallen by 26.2% this
quarter.
* The company reported a quarterly loss of $23.59 million.
* Wall Street's median 12-month price target for Bolt
Biotherapeutics Inc is $39.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:35 p.m.  ​All
figures in US dollars unless otherwise stated